Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073104311> ?p ?o ?g. }
- W2073104311 endingPage "2139" @default.
- W2073104311 startingPage "2130" @default.
- W2073104311 abstract "To investigate whether interactions of sulfasalazine (SSZ) with reduced folate carrier (RFC), the dominant cell membrane transporter for natural folates and methotrexate (MTX), may limit the efficacy of combination therapy with MTX and SSZ in patients with rheumatoid arthritis.Human RFC-(over)expressing CEM cells of T cell origin were used to analyze the effect of SSZ on the RFC-mediated cellular uptake of radiolabeled MTX and the natural folate leucovorin. Moreover, both cells with and those without acquired resistance to SSZ were used to assess the antiproliferative effects of MTX in combination with SSZ.Transport kinetic analyses revealed that SSZ was a potent noncompetitive inhibitor of RFC-mediated cellular uptake of MTX and leucovorin, with mean +/- SD K(i) (50% inhibitory concentration) values of 36 +/- 6 microM and 74 +/- 7 microM, respectively. Consistent with the inhibitory interaction of SSZ with RFC, a marked loss of MTX efficacy was observed when MTX was coadministered with SSZ: up to 3.5-fold for CEM cells in the presence of 0.25 mM of SSZ, and >400-fold for SSZ-resistant cells in the presence of 2.5 mM of SSZ. Importantly, along with diminished efficacy of MTX, evidence for cellular folate depletion was obtained by the demonstration of an SSZ dose-dependent decrease in leucovorin accumulation.At clinically relevant plasma concentrations, interactions of SSZ with RFC provide a biochemical rationale for 2 important clinical observations: 1) the onset of (sub)clinical folate deficiency during SSZ treatment, and 2) the lack of additivity/synergism of the combination of SSZ and MTX when these disease-modifying antirheumatic drugs are administered simultaneously. Thus, when considering use of these drugs in combination therapies, the present results provide a rationale both for the use of folate supplementation and for spacing administration of these drugs over time." @default.
- W2073104311 created "2016-06-24" @default.
- W2073104311 creator A5007946879 @default.
- W2073104311 creator A5013852274 @default.
- W2073104311 creator A5066790265 @default.
- W2073104311 creator A5070195777 @default.
- W2073104311 creator A5072587294 @default.
- W2073104311 creator A5075695885 @default.
- W2073104311 creator A5085213730 @default.
- W2073104311 creator A5085426388 @default.
- W2073104311 date "2004-01-01" @default.
- W2073104311 modified "2023-10-10" @default.
- W2073104311 title "Sulfasalazine is a potent inhibitor of the reduced folate carrier: Implications for combination therapies with methotrexate in rheumatoid arthritis" @default.
- W2073104311 cites W12049018 @default.
- W2073104311 cites W127370022 @default.
- W2073104311 cites W1519255610 @default.
- W2073104311 cites W1562169645 @default.
- W2073104311 cites W1727714355 @default.
- W2073104311 cites W1896127315 @default.
- W2073104311 cites W1928865219 @default.
- W2073104311 cites W193344852 @default.
- W2073104311 cites W1964260529 @default.
- W2073104311 cites W1968285538 @default.
- W2073104311 cites W1971768752 @default.
- W2073104311 cites W1976147300 @default.
- W2073104311 cites W1978987007 @default.
- W2073104311 cites W1979012566 @default.
- W2073104311 cites W1982348705 @default.
- W2073104311 cites W1986979527 @default.
- W2073104311 cites W1988848155 @default.
- W2073104311 cites W1990321660 @default.
- W2073104311 cites W1993899589 @default.
- W2073104311 cites W1994030928 @default.
- W2073104311 cites W1996203160 @default.
- W2073104311 cites W2004036980 @default.
- W2073104311 cites W2012635718 @default.
- W2073104311 cites W2014878554 @default.
- W2073104311 cites W2019099466 @default.
- W2073104311 cites W2021841372 @default.
- W2073104311 cites W2043024112 @default.
- W2073104311 cites W2055552041 @default.
- W2073104311 cites W2059231550 @default.
- W2073104311 cites W2059717105 @default.
- W2073104311 cites W2074228821 @default.
- W2073104311 cites W2075437346 @default.
- W2073104311 cites W2086452331 @default.
- W2073104311 cites W2096886481 @default.
- W2073104311 cites W2101549937 @default.
- W2073104311 cites W2102561304 @default.
- W2073104311 cites W2111750347 @default.
- W2073104311 cites W2115068422 @default.
- W2073104311 cites W2115614832 @default.
- W2073104311 cites W2124525707 @default.
- W2073104311 cites W2132716765 @default.
- W2073104311 cites W2133837925 @default.
- W2073104311 cites W2135935949 @default.
- W2073104311 cites W2139063743 @default.
- W2073104311 cites W2140744545 @default.
- W2073104311 cites W2141161224 @default.
- W2073104311 cites W2146455486 @default.
- W2073104311 cites W2147017735 @default.
- W2073104311 cites W2149026148 @default.
- W2073104311 cites W2149195756 @default.
- W2073104311 cites W2151661622 @default.
- W2073104311 cites W2158392523 @default.
- W2073104311 cites W2164759986 @default.
- W2073104311 cites W2258754807 @default.
- W2073104311 cites W2319957449 @default.
- W2073104311 cites W2320562573 @default.
- W2073104311 cites W2339867635 @default.
- W2073104311 cites W2340084730 @default.
- W2073104311 cites W4301499817 @default.
- W2073104311 doi "https://doi.org/10.1002/art.20375" @default.
- W2073104311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15248210" @default.
- W2073104311 hasPublicationYear "2004" @default.
- W2073104311 type Work @default.
- W2073104311 sameAs 2073104311 @default.
- W2073104311 citedByCount "78" @default.
- W2073104311 countsByYear W20731043112012 @default.
- W2073104311 countsByYear W20731043112013 @default.
- W2073104311 countsByYear W20731043112014 @default.
- W2073104311 countsByYear W20731043112015 @default.
- W2073104311 countsByYear W20731043112016 @default.
- W2073104311 countsByYear W20731043112018 @default.
- W2073104311 countsByYear W20731043112019 @default.
- W2073104311 countsByYear W20731043112020 @default.
- W2073104311 countsByYear W20731043112021 @default.
- W2073104311 countsByYear W20731043112022 @default.
- W2073104311 countsByYear W20731043112023 @default.
- W2073104311 crossrefType "journal-article" @default.
- W2073104311 hasAuthorship W2073104311A5007946879 @default.
- W2073104311 hasAuthorship W2073104311A5013852274 @default.
- W2073104311 hasAuthorship W2073104311A5066790265 @default.
- W2073104311 hasAuthorship W2073104311A5070195777 @default.
- W2073104311 hasAuthorship W2073104311A5072587294 @default.
- W2073104311 hasAuthorship W2073104311A5075695885 @default.
- W2073104311 hasAuthorship W2073104311A5085213730 @default.
- W2073104311 hasAuthorship W2073104311A5085426388 @default.